Status:
UNKNOWN
Ex Vivo Study of the Heracure Device for Intra-uterine Morcellation After Vaginal or Laparoscopic Hysterectomy
Lead Sponsor:
Heracure Medical Ltd.
Conditions:
Vaginal or Laparoscopic Hysterectomy
Eligibility:
FEMALE
21+ years
Phase:
NA
Brief Summary
Safety and performance evaluation of the Heracure Device for intra-uterine morcellation after vaginal or laparoscopic hysterectomy.
Detailed Description
The purpose of this clinical investigation is to evaluate the safety and efficacy of the Heracure Device for intra-uterine morcellation after vaginal or laparoscopic hysterectomy.
Eligibility Criteria
Inclusion
- Subject is undergoing hysterectomy due to benign gynecologic disease
Exclusion
- Subject is not suspected of malignancy
Key Trial Info
Start Date :
April 18 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT05332132
Start Date
April 18 2022
End Date
December 31 2022
Last Update
May 25 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Meir Medical Center
Kfar Saba, Israel